Addus HomeCare (NASDAQ:ADUS) Price Target Raised to $150.00

Addus HomeCare (NASDAQ:ADUSGet Free Report) had its price objective lifted by analysts at Oppenheimer from $145.00 to $150.00 in a report issued on Friday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s target price points to a potential upside of 16.88% from the stock’s current price.

Several other analysts also recently issued reports on the stock. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Friday. Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Stephens lifted their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. Macquarie reissued an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. Finally, KeyCorp began coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price on the stock. One analyst has rated the stock with a sell rating, nine have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $134.22.

View Our Latest Analysis on Addus HomeCare

Addus HomeCare Trading Up 1.0 %

ADUS traded up $1.23 during trading hours on Friday, hitting $128.34. The company’s stock had a trading volume of 28,719 shares, compared to its average volume of 131,686. The stock has a market cap of $2.33 billion, a price-to-earnings ratio of 29.39, a P/E/G ratio of 1.73 and a beta of 1.00. The business’s 50-day moving average price is $125.88 and its 200-day moving average price is $126.88. Addus HomeCare has a 12 month low of $85.94 and a 12 month high of $136.72.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. During the same quarter in the previous year, the company posted $1.03 EPS. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. On average, analysts forecast that Addus HomeCare will post 4.58 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the sale, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 39,750 shares of company stock valued at $4,930,750. Company insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Janney Montgomery Scott LLC grew its holdings in Addus HomeCare by 0.9% during the fourth quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company’s stock valued at $1,340,000 after purchasing an additional 91 shares during the last quarter. Inspire Investing LLC raised its stake in shares of Addus HomeCare by 3.3% in the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock valued at $414,000 after acquiring an additional 100 shares during the last quarter. New York State Teachers Retirement System increased its holdings in shares of Addus HomeCare by 1.2% in the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock valued at $1,132,000 after purchasing an additional 100 shares in the last quarter. Equitable Trust Co. lifted its holdings in Addus HomeCare by 2.2% in the third quarter. Equitable Trust Co. now owns 4,825 shares of the company’s stock valued at $642,000 after buying an additional 106 shares during the period. Finally, Royce & Associates LP grew its holdings in Addus HomeCare by 1.2% during the third quarter. Royce & Associates LP now owns 8,924 shares of the company’s stock valued at $1,187,000 after purchasing an additional 109 shares during the period. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Stories

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.